Although several preclinical anti-cancer outcomes have been achieved, such as with ferroptosis inducers, translating oxidative cell death mechanisms into effective clinical therapies requires rigorous testing, including assessments of bioavailability, toxicity, and off-target effects
A 2025 intravenous safety study involving two healthy adults found infusions up to 20 mg well tolerated, with no adverse events or clinically meaningful changes in vital signs or laboratory biomarkers
Chechowska M, Gajewska J, Szczepanik E, Mazur J, Cychol A, Kuniar-Paka A, Ambroszkiewicz J (2025) Oxidative stress indicated by nuclear transcription factor Nrf2 and glutathione status in the blood of young children with autism spectrum disorder: pilot study
We do not know whether the buccal absorption of methylcobalamin from an ODT is sufficient to fully compensate for the B12 absorption impairment caused by semaglutide
Meta-analysis of the relationship between CXCR4 expression and metastasis in prostate Cancer